A brief dive into the phenomenon of cisplatin resistance in non-small-cell lung cancer

Volume: 17, Pages: 37 - 41
Published: Sep 29, 2021
Abstract
Lung cancer is one of the most lethal types of cancer due to a lack of proper treatment. The rare presence of molecular therapy targets forces the use of platinum-based drugs. Cisplatin, approved by the USA as an anticancer therapy in the 1970s, is still one of the most prominent therapies against lung cancer. Unfortunately, the biggest limitation of cisplatin-based therapy is the development of cisplatin resistance. Cancer cells overcome the...
Paper Details
Title
A brief dive into the phenomenon of cisplatin resistance in non-small-cell lung cancer
Published Date
Sep 29, 2021
Volume
17
Pages
37 - 41
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.